Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate

Authors:

Abstract
SUMMARY: Bismuth concentration was measured in plasma, dried leucocytes and urie in nine patients before, during and after treatment with tripotassium dicitrato bismuthate (De‐Noltab 2 b.d.) for 6 weeks. During treatment there was an 8.5‐fold rise in median plasma bismuth concentration (P < 0.01), a non‐significant doubling of leucocyte bismuth content, and a 349‐fold rise in 24‐h urinary bismuth excretion (P < 0.01). The significantly increased urinary bismuth excretion continued for at least 3 months after cessation of treatment with tripotassium dicitrato bismuthate, indicating accumulation of bismuth during treatment with this drug.

This publication has 21 references indexed in Scilit: